tiprankstipranks
NRX Pharmaceuticals Eyes $30M Refinancing and Funding Deal
PremiumCompany AnnouncementsNRX Pharmaceuticals Eyes $30M Refinancing and Funding Deal
2M ago
NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2024 Financial Results and Provides Business Update
PremiumPress Releases
NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2024 Financial Results and Provides Business Update
2M ago
NRx Pharmaceuticals reports final trial results of NRX-101
PremiumThe Fly
NRx Pharmaceuticals reports final trial results of NRX-101
3M ago
NRx Pharmaceuticals announces new data on NRX-101
PremiumThe FlyNRx Pharmaceuticals announces new data on NRX-101
3M ago
NRx Pharmaceuticals develops new proprietary formulation of HTX-100
PremiumThe Fly
NRx Pharmaceuticals develops new proprietary formulation of HTX-100
3M ago
NRx Pharmaceuticals achieves data-lock of Phase 2b/3 trial of NRX-101
PremiumThe Fly
NRx Pharmaceuticals achieves data-lock of Phase 2b/3 trial of NRX-101
3M ago
NRx Pharmaceuticals sees FY23 EPS (40c), consensus (37c)
PremiumThe FlyNRx Pharmaceuticals sees FY23 EPS (40c), consensus (37c)
4M ago
NRx Pharmaceuticals announces 1-for-10 reverse stock split
PremiumThe Fly
NRx Pharmaceuticals announces 1-for-10 reverse stock split
4M ago
Is NRXP a Buy, Before Earnings?
PremiumPre-Earnings
Is NRXP a Buy, Before Earnings?
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100